| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 04/03/2002 | EP0874645B1 Perfluoroalkyl-containing metal complexes and their use in nmr diagnostics |
| 04/02/2002 | US6365797 Prostate cancer cell line; for use in animal models |
| 04/02/2002 | US6365402 Growth differentiation factor-9 |
| 04/02/2002 | US6365351 Non-invasive method for detecting target RNA |
| 04/02/2002 | US6365129 Concurrent analyzing different compounds |
| 04/02/2002 | US6365128 Administering vasoactive intestinal peptide; monitoring; calibration |
| 03/29/2002 | CA2357450A1 Phenoxazine analogs useful as amyloid aggregation inhibitors and treatment of alzheimer's disease and disorders related to amyloidosis |
| 03/28/2002 | WO2002025270A1 Screening systems and methods for identifying modulators of xenobiotic metabolism |
| 03/28/2002 | WO2002024924A2 Protein phosphatases |
| 03/28/2002 | WO2002024727A2 New inhibitors of iapp fibril formation and uses thereof |
| 03/28/2002 | WO2002024695A2 Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines |
| 03/28/2002 | WO2002024680A1 Imidazole derivatives as raf kinase inhibitors |
| 03/28/2002 | WO2002024235A2 Prochelators of radiometal labeled molecules |
| 03/28/2002 | WO2002024226A2 Photosensitisers |
| 03/28/2002 | WO2001070977A3 Fibroblast growth factor receptor-like molecules and uses thereof |
| 03/28/2002 | WO2001069199A3 Methods of detecting cancer using cellular autofluorescence |
| 03/28/2002 | US20020038133 Absorbable sponge with contrasting agent |
| 03/28/2002 | US20020038087 Imageable biopsy site marker |
| 03/28/2002 | US20020037585 Detecting modulator of preferential gene expression; obtain cell from human or nematode, incubate cells with modulator, monitor cells for decrease in preferential gene expresssion |
| 03/28/2002 | US20020037289 Combined methods and compositions for tumor vasculature targeting and tumor treatment |
| 03/28/2002 | US20020037287 For diagnosis and therapy of myeloma and ovarian cancer |
| 03/28/2002 | US20020037265 Preparation for breast duct fluid collection |
| 03/28/2002 | US20020037254 Conjugate for differentiating between healthy and unhealthy tissue |
| 03/28/2002 | US20020037253 Functionalized active-nucleus complex sensor |
| 03/28/2002 | US20020037252 Gamma radiation emitted from a near-infrared fluorescent colorant injected in advance into the vicinity of a tumor is detected by use of a gamma-probe. |
| 03/28/2002 | US20020037250 Polynucleotides and polypeptides which are diagnostic markers for mammary gland cancer. |
| 03/28/2002 | US20020035836 Polarized gas accumulators and heating jackets and associated gas collection and thaw methods and polarized gas products |
| 03/28/2002 | DE10040858A1 Perfluoralkylhaltige Komplexe mit polaren Resten, Verfahren zu deren Herstellung und ihre Verwendung Perfluoroalkyl-containing complexes with polar radicals, process for their preparation and their use |
| 03/28/2002 | DE10037832A1 Kontrastmittel für medizinische Diagnostik Contrast agents for medical diagnosis |
| 03/28/2002 | CA2423284A1 Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines |
| 03/28/2002 | CA2423154A1 Imidazole derivatives as raf kinase inhibitors |
| 03/28/2002 | CA2422921A1 Screening systems and methods for identifying modulators of xenobiotic metabolism |
| 03/28/2002 | CA2422911A1 New inhibitors of iapp fibril formation and uses thereof |
| 03/28/2002 | CA2420862A1 Protein phosphatases |
| 03/27/2002 | EP1191099A1 Novel polypeptide and dna thereof |
| 03/27/2002 | EP1189942A1 Somatostatin agonists |
| 03/27/2002 | EP1189645A2 Non-covalent bioconjugates useful for diagnosis and therapy |
| 03/27/2002 | EP1189546A1 Biopsy site marker and process and apparatus for applying it |
| 03/27/2002 | EP1047454A4 Methods of screening compounds useful for prevention of infection or pathogenicity |
| 03/27/2002 | EP0964705B1 Testkit |
| 03/27/2002 | EP0779821B1 Improvements in or relating to contrast agents |
| 03/27/2002 | CN1081467C Preparing liquid for producing ultrasonic diagnostic contrast medium and method of preparing contrast medium therewith |
| 03/26/2002 | US6361792 Fluorocarbon emulsion and nonsteroid antiinflammatory agent, antipyretic, nonnarcotic analgesic |
| 03/26/2002 | US6361759 Coating for visualizing medical devices in magnetic resonance imaging, comprising complex of polymer with surface functional group selected from amino group and carboxyl group, chelate, paramagnetic ion, and lactam linker or spacer molecule |
| 03/26/2002 | US6361713 Displacing water from and decontaminating surfaces |
| 03/26/2002 | CA1341351C Production of chimeric mouse-human antibodies with specificity to human tumor antigens |
| 03/21/2002 | WO2002023210A1 Method of magnetic resonance investigation of a sample using a nuclear spin polarised mr imaging agent |
| 03/21/2002 | WO2002022882A2 Target activated nucleic acid biosensor and methods of using same |
| 03/21/2002 | WO2002022186A1 Hydrophilic, lubricious medical devices having contrast for magnetic resonance imaging |
| 03/21/2002 | WO2002022011A1 Method for pictorially depicting and diagnosing thrombi by means of nuclear spin tomography involving the use of particulate contrast agents |
| 03/21/2002 | WO2002021996A2 Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators |
| 03/21/2002 | WO2002005803A8 Functionalized active-nucleus complex sensor |
| 03/21/2002 | WO2001068700A3 Regulation of human substance p-like g protein-coupled receptor |
| 03/21/2002 | WO2001037779A3 A novel method of diagnosing, monitoring, staging, imaging and treating breast cancer |
| 03/21/2002 | WO2001030398A3 Ligand chelated paramagnetic mri contrast agents |
| 03/21/2002 | US20020035736 HER2-transgenic non-human tumor model |
| 03/21/2002 | US20020035324 Subcutaneous cavity marking device and method |
| 03/21/2002 | US20020035122 8-azabicyclo[3.2.1]oct-2-ene and -octane derivatives |
| 03/21/2002 | US20020034770 Modulators of cyclin dependent kinases; for use in the treatment of cancer; antitumor agents |
| 03/21/2002 | US20020034537 For enhancing selective delivery of therapeutic, diagnostic and imaging agents to activated vascular sites |
| 03/21/2002 | US20020034476 Bioactivated diagnostic imaging contrast agents |
| 03/21/2002 | US20020034472 Diagnosis of central nervous system disorders |
| 03/21/2002 | US20020033989 Methods and apparatus for optical imaging |
| 03/21/2002 | CA2422278A1 Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators |
| 03/21/2002 | CA2418724A1 Target activated nucleic acid biosensor and methods of using same |
| 03/21/2002 | CA2417716A1 Mri method involving the use of a hyperpolarized contrast agent |
| 03/20/2002 | EP1188051A1 Bulk production and usage of hyperpolarized ?129 xenon |
| 03/19/2002 | US6359119 Reacting a metal in permetallate form in a mixture with carbon monoxide and a reducing agent comprising stannous salt to form carbonyl complex |
| 03/19/2002 | US6359111 Useful in treating cancer, and in a method of imaging opioid receptors either inside or outside of the central nervous system |
| 03/19/2002 | US6359006 Antiischemic agents; anticancer agents |
| 03/19/2002 | CA1341349C Functionalized polyamine chelants and rhodium complexes thereof for conjugation to antibodies |
| 03/14/2002 | WO2002021134A2 Methods of diagnosing breast cancer and screening for modulators |
| 03/14/2002 | WO2002020822A2 Biopanning and rapid analysis of selective interactive ligands (brasil) |
| 03/14/2002 | WO2002020769A1 Human and mouse targeting peptides identified by phage display |
| 03/14/2002 | WO2002020724A2 Adenoviral targeting and manipulation of immune system response using targeting peptides |
| 03/14/2002 | WO2002020723A2 Compositions and methods for targeting peptides in humans in vivo |
| 03/14/2002 | WO2002020722A2 Methods and compositions for in vitro targeting |
| 03/14/2002 | WO2002020610A2 Conformationally constrained labeled peptides for imaging and therapy |
| 03/14/2002 | WO2002020061A1 Preparations for diagnosing extrapancreatic secretory function |
| 03/14/2002 | WO2002020047A2 Chlamydial peptides and their mimics in demyelinating disease |
| 03/14/2002 | WO2002020015A1 Inhibitors of prenyl-protein transferase |
| 03/14/2002 | WO2002020005A1 Use of arginine in endoscopy and other medical procedures |
| 03/14/2002 | WO2002020003A2 Use of carp inhibitors for the treatment of heart diseases |
| 03/14/2002 | WO2001085756A3 Site-selective acyl transfer |
| 03/14/2002 | WO2001076644A3 Lipid-based systems for targeting diagnostic agents |
| 03/14/2002 | WO2001076555A3 Lipid-based drug delivery systems for topical application |
| 03/14/2002 | WO2001049184A3 Radiofrequency apparatus and method for accessing a biopsy site |
| 03/14/2002 | WO2001008712A3 Targeting multimeric imaging agents through multilocus binding |
| 03/14/2002 | US20020032149 Monitoring blood flow parameter of bloodstream, administering substance to organism such that an amount of substance enters bloodstream; distributing portion of amount ofsubstance target within organism |
| 03/14/2002 | US20020031781 Signal enhancement of bispecific antibody-polymer probe for immunoassay use |
| 03/14/2002 | US20020031476 Stabilized gas emulsion containing phospholipid for ultrasound contrast enhancement |
| 03/14/2002 | US20020031475 To give better sensitivity |
| 03/14/2002 | US20020031474 Endoscopy tissue stain |
| 03/14/2002 | US20020031473 In vivo chemosensitivity screen for human tumors |
| 03/14/2002 | DE10043124A1 Verfahren zur Diagnostik von neuronalen Erkrankungen sowie zur Behandlung der defizienten primären Hämostase Method for the diagnosis of neural disorders and for the treatment of primary hemostasis deficiency |
| 03/14/2002 | CA2730627A1 Human and mouse targeting peptides identified by phage display |
| 03/14/2002 | CA2421834A1 Use of carp inhibitors for the treatment of heart diseases |
| 03/14/2002 | CA2421380A1 Biopanning and rapid analysis of selective interactive ligands (brasil) |
| 03/14/2002 | CA2421271A1 Human and mouse targeting peptides identified by phage display |
| 03/14/2002 | CA2421200A1 Adenoviral targeting and manipulation of immune system response using targeting peptides |